Aspirin Resistance Reversibility in Diabetic Patients

NCT01935193 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Aspirin Resistance

Interventions

DRUG: lysine acetylsalicylate

Sponsor

Azienda Ospedaliera San Giovanni Battista